New User? Sign Up | Sign In

Insider Trading - Woiwode Thomas

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Trading Transactions for Woiwode Thomas

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2016-07-25
Purchase
2016-07-25
5:09 pm
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
35,000 $15 $525,000 11,308
(Indirect)
View
2016-10-18
Purchase
2016-12-23
6:03 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
161,000 $14 $2,254,000 185,987
(Indirect)
View
2017-11-24
Sale
2017-11-28
4:11 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,900 $20.21 $38,406 8,018
(Direct)
View
2017-12-22
Sale
2017-12-27
4:14 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
3,059 $20.29 $62,070 4,959
(Direct)
View
2018-04-20
Sale
2018-04-24
7:42 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
101,994 $50.68 $5,168,901 117,173
(Indirect
Direct)
View
2018-04-24
Sale
2018-04-26
5:01 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
22,841 $50.99 $1,164,655 115,645
(Indirect)
View
2018-04-26
Sale
2018-04-30
8:57 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
222,258 $50.11 $11,136,437 100,780
(Indirect)
View
2018-04-30
Sale
2018-05-02
6:00 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,566 $50.29 $1,537,138 98,736
(Indirect
Direct)
View
2018-05-07
Sale
2018-05-09
5:15 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
121,362 $50.39 $6,115,873 5,629
(Indirect
Direct)
View
2018-05-15
Sale
2018-05-17
5:11 pm
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
44,000 $57.99 $2,551,440 640,014
(Indirect
Direct)
View
2020-03-03
Purchase
2020-03-03
6:57 pm
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
225,000 $18 $4,050,000 933,352
(Indirect)
View
2020-03-03
Purchase
2020-03-03
7:03 pm
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
225,000 $18 $4,050,000 933,352
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2016-05-11
Option Award
2016-07-01
6:18 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
24,155 $0 44,248
(Direct)
View
2016-05-11
Option Award
2016-07-01
6:18 pm
N/A
2026-05-10
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
44,248 $4.14 44,248
(Direct)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
1,081,477 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
480,856 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
198,410 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
6,811 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
3,029 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
1,249 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
1,081,477 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
480,856 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
198,410 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
6,811 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
3,029 $0 11,308
(Indirect)
View
2016-07-25
Conversion
2016-07-25
5:09 pm
N/A
N/A
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
1,249 $0 11,308
(Indirect)
View
2016-08-24
Option Award
2016-08-25
9:55 pm
N/A
2026-08-24
Audentes Therapeutics Inc. BOLD Woiwode Thomas
Director
18,000 $15.03 18,000
(Direct)
View
2016-10-18
Option Award
2016-10-20
5:14 pm
N/A
2026-10-18
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $14 30,000
(Direct)
View
2016-10-31
Option Award
2016-11-01
6:48 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,390 $0 27,545
(Direct)
View
2016-11-30
Option Award
2016-12-01
6:05 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,509 $0 31,054
(Direct)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
437,247 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
3,100,477 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
231,077 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,754 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
19,524 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,454 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,210,417 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
173,167 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
66,490 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
5,210 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
168,224 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
13,180 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
73,704 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
5,774 $0 185,987
(Indirect)
View
2016-10-18
Option Award
2016-12-23
6:03 pm
N/A
2026-10-18
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $14 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
437,247 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,754 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
3,100,477 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
19,524 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,210,417 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
66,490 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
168,224 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
73,704 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
231,077 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,454 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
173,167 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
5,210 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
13,180 $0 185,987
(Indirect)
View
2016-10-18
Conversion
2016-12-23
6:03 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
5,774 $0 185,987
(Indirect)
View
2016-12-30
Option Award
2017-01-03
5:27 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,449 $0 34,503
(Direct)
View
2017-01-31
Option Award
2017-02-02
4:41 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,449 $0 37,952
(Direct)
View
2017-02-28
Option Award
2017-03-02
4:58 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,774 $0 41,726
(Direct)
View
2017-03-31
Option Award
2017-04-03
5:57 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
3,704 $0 45,430
(Direct)
View
2017-04-28
Option Award
2017-05-01
8:20 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
2,223 $0 47,653
(Direct)
View
2017-05-31
Option Award
2017-06-02
4:30 pm
N/A
2027-05-31
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $13.62 30,000
(Indirect)
View
2017-06-12
Option Award
2017-06-14
7:11 pm
N/A
N/A
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
22,727 $0 33,602
(Direct)
View
2017-06-12
Option Award
2017-06-14
7:11 pm
2018-06-12
2027-06-11
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
33,602 $2.75 33,602
(Direct)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,368,013 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
8,110 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
814,599 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
23,899 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
61,993 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
26,491 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
292,529 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
292,529 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
17,283 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
17,283 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,240 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
1,240 $0 9,918
(Indirect)
View
2017-09-05
Other
2017-09-07
9:33 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
9,918 $0 9,918
(Direct)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
497,053 $0 117,173
(Indirect)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,947 $0 117,173
(Indirect)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
92,918 $0 117,173
(Indirect)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
92,918 $0 117,173
(Indirect)
View
2018-04-20
Other
2018-04-24
7:42 pm
N/A
N/A
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
2,323 $0 117,173
(Direct)
View
2018-05-31
Option Award
2018-06-15
4:27 pm
N/A
2028-05-30
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
35,000 $6.25 35,000
(Direct)
View
2018-06-15
Option Award
2018-06-15
9:39 pm
N/A
2028-06-15
CRISPR Therapeutics AG CRSP Woiwode Thomas
Director
30,000 $59.31 30,000
(Indirect)
View
2018-10-02
Conversion
2018-10-02
5:29 pm
N/A
N/A
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
3,102,929 $0 0
(Indirect)
View
2018-10-02
Conversion
2018-10-02
5:29 pm
N/A
N/A
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
2,173,909 $0 0
(Indirect)
View
2018-10-02
Conversion
2018-10-02
5:29 pm
N/A
N/A
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
929,020 $0 0
(Indirect)
View
2019-06-19
Option Award
2019-06-20
4:17 pm
N/A
2029-06-19
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
8,570 $10.86 8,570
(Direct)
View
2019-07-31
Option Award
2019-08-02
4:25 pm
N/A
2029-07-30
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
45,000 $13.41 45,000
(Direct)
View
2020-02-27
Option Award
2020-03-02
6:01 pm
N/A
2030-02-27
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
33,836 $18 33,836
(Direct)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
2,977,242 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
1,049,175 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
708,352 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
2,977,242 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
1,049,175 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
6:57 pm
N/A
N/A
Passage BIO Inc. PASG Woiwode Thomas
Director
10% Owner
708,352 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
2,977,242 $0 933,352
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
1,049,175 $0 933,352
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
708,352 $0 933,352
(Indirect)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
2,977,242 $0 933,352
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
1,049,175 $0 933,352
(Direct)
View
2020-03-03
Conversion
2020-03-03
7:03 pm
N/A
N/A
Passage BIO Inc. PASG Versant Venture Capital VI L.P.
Versant Ventures VI GP L.P.
Versant Ventures VI GP-GP LLC
Versant Vantage I L.P.
Versant Vantage I GP L.P.
Versant Vantage I GP-GP LLC
Woiwode Thomas
10% Owner
708,352 $0 933,352
(Indirect)
View
2020-06-18
Option Award
2020-06-22
5:40 pm
N/A
2030-06-18
Gritstone Oncology Inc. GRTS Woiwode Thomas
Director
10% Owner
12,500 $6.66 12,500
(Direct)
View
2020-06-23
Option Award
2020-06-25
5:45 pm
N/A
2030-06-22
Adverum Biotechnologies Inc. ADVM Woiwode Thomas
Director
30,000 $25.64 30,000
(Direct)
View